FDA Food EnforcementMedium / 中

RepairVite (K63), Enzyme-Based Herbal & Amino Acid Dietary Supplement Powder, Caramel Flavor, Net Wt. 0.34 lb (155g)

Recall F-0144-2014Published 2013-11-20Company Apex Energetics
Reason / 召回原因Apex Energetics is recalling GlutenFlam, SuperDigestZyme, LGS-Zyme, and RepairVite because they may contain trace amounts of the antibiotic chloramphenicol. The dietary supplements on recall contain enzymes that are on recall by Specialty Enzymes Biotechnology, a raw material supplier, because it contains chloramphenicol.
Distribution / 销售地区Nationwide in US and worldwide to Canada, United Kingdom
Code information / 批次信息Lot# 302048 304003 306007
i

Official-information notice / 官方信息说明
This page organizes fields from the named agency record. It is not medical, legal, or food-safety advice. Always compare your package with the official notice.

Official record details

官方记录详情:以原始机构公告为准

Recall number / 召回编号

F-0144-2014

Classification / 风险等级

Medium / 中

Published / 发布时间

2013-11-20

Recalling firm / 召回企业

Apex Energetics

Product description / 产品描述

RepairVite (K63), Enzyme-Based Herbal & Amino Acid Dietary Supplement Powder, Caramel Flavor, Net Wt. 0.34 lb (155g)

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Lot# 302048 304003 306007

Product quantity / 产品数量

8117 units

Distribution / 销售地区

Nationwide in US and worldwide to Canada, United Kingdom

Reason for recall / 召回原因

Apex Energetics is recalling GlutenFlam, SuperDigestZyme, LGS-Zyme, and RepairVite because they may contain trace amounts of the antibiotic chloramphenicol. The dietary supplements on recall contain enzymes that are on recall by Specialty Enzymes Biotechnology, a raw material supplier, because it contains chloramphenicol.

Need the original notice?
Open the agency source for the complete official notice and any disposal, return, or contact instructions.

Open official source ↗

← Return to Recall Radar search / 返回搜索雷达

Last synchronized: 2026-08-09. Recall Radar does not replace agency guidance.